Selby Warwick S, Griffin Sean, Abraham Ned, Solomon Michael J
A. W. Morrow Gastroenterology and Liver Centre and Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Am J Gastroenterol. 2002 Nov;97(11):2834-8. doi: 10.1111/j.1572-0241.2002.07049.x.
Appendectomy has been shown to protect against the development of ulcerative colitis. The objective of this study was to examine the effect of appendectomy on the clinical features and natural history of colitis.
A total of 259 consecutive adults patients with ulcerative colitis were studied. Of the patients, 20 had undergone appendectomy (12 before onset of colitis and eight after diagnosis).
The frequency of appendectomy was significantly less than in a group of 280 controls, which comprised partners of the patients and a group from the community (OR = 0.25; 95% CI = 0.14-0.44). This was even more significant if only the 12 patients who underwent surgery before the onset of colitis were considered (OR = 0.15; 95% CI = 0.07-0.28). Patients with prior appendectomy developed symptoms of ulcerative colitis for the first time at a significantly later age than those without appendectomy (42.5 +/- 6.5 vs 32.1 +/- 0.8 yr; p < 0.01) or those who had appendectomy after the onset of colitis (24.6 +/- 3.4 yr; p < 0.05). Appendectomy did not influence disease extent, need for immunosuppressive treatment with azathioprine or 6-mercaptopurine (as a marker of resistant disease), or the likelihood of colectomy. Five patients in the appendectomy group had clinical evidence of primary sclerosing cholangitis (25%). This was more common than in those without appendectomy (8%; OR = 4.09; 95% CI = 1.04-13.60).
These results indicate that although appendectomy may delay onset of colitis, it does not influence its course. However, it is associated with the development of primary sclerosing cholangitis. Appendectomy is unlikely to be of benefit in established ulcerative colitis.
已证实阑尾切除术可预防溃疡性结肠炎的发生。本研究的目的是探讨阑尾切除术对结肠炎临床特征及自然病程的影响。
共研究了259例连续性成年溃疡性结肠炎患者。其中,20例接受过阑尾切除术(12例在结肠炎发病前,8例在诊断后)。
阑尾切除术的发生率显著低于由患者配偶及社区人群组成的280例对照组(比值比=0.25;95%可信区间=0.14-0.44)。若仅考虑12例在结肠炎发病前行手术的患者,这一差异更为显著(比值比=0.15;95%可信区间=0.07-0.28)。既往接受阑尾切除术的患者首次出现溃疡性结肠炎症状的年龄显著晚于未接受阑尾切除术的患者(42.5±6.5岁对32.1±0.8岁;P<0.01)或在结肠炎发病后接受阑尾切除术的患者(24.6±3.4岁;P<0.05)。阑尾切除术不影响疾病范围、使用硫唑嘌呤或6-巯基嘌呤进行免疫抑制治疗的必要性(作为难治性疾病的标志物)或结肠切除术的可能性。阑尾切除术组中有5例患者有原发性硬化性胆管炎的临床证据(25%)。这比未接受阑尾切除术的患者更常见(8%;比值比=4.09;95%可信区间=1.04-13.60)。
这些结果表明,虽然阑尾切除术可能会延迟结肠炎的发病,但不影响其病程。然而,它与原发性硬化性胆管炎的发生有关。阑尾切除术对已确诊的溃疡性结肠炎不太可能有益。